- Home
- AVIR vs TTEC Comparison
AVIR vs TTEC Comparison
Compare AVIR & TTEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- TTEC
- Stock Information
- Founded
- AVIR 2012
- TTEC 1982
- Country
- AVIR United States
- TTEC United States
- Employees
- AVIR N/A
- TTEC N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- TTEC Retail: Computer Software & Peripheral Equipment
- Sector
- AVIR Health Care
- TTEC Technology
- Exchange
- AVIR Nasdaq
- TTEC Nasdaq
- Market Cap
- AVIR 276.9M
- TTEC 229.6M
- IPO Year
- AVIR 2020
- TTEC 1996
- Fundamental
- Price
- AVIR $3.25
- TTEC $4.81
- Analyst Decision
- AVIR Hold
- TTEC Buy
- Analyst Count
- AVIR 1
- TTEC 5
- Target Price
- AVIR $6.88
- TTEC $11.17
- AVG Volume (30 Days)
- AVIR 178.7K
- TTEC 518.1K
- Earning Date
- AVIR 11-07-2024
- TTEC 11-06-2024
- Dividend Yield
- AVIR N/A
- TTEC 12.06%
- EPS Growth
- AVIR N/A
- TTEC N/A
- EPS
- AVIR N/A
- TTEC N/A
- Revenue
- AVIR N/A
- TTEC $2,266,331,000.00
- Revenue This Year
- AVIR N/A
- TTEC N/A
- Revenue Next Year
- AVIR N/A
- TTEC $0.84
- P/E Ratio
- AVIR N/A
- TTEC N/A
- Revenue Growth
- AVIR N/A
- TTEC N/A
- 52 Week Low
- AVIR $2.81
- TTEC $3.67
- 52 Week High
- AVIR $4.60
- TTEC $22.70
- Technical
- Relative Strength Index (RSI)
- AVIR 44.03
- TTEC 46.50
- Support Level
- AVIR $3.10
- TTEC $4.17
- Resistance Level
- AVIR $3.48
- TTEC $5.06
- Average True Range (ATR)
- AVIR 0.13
- TTEC 0.33
- MACD
- AVIR -0.01
- TTEC -0.04
- Stochastic Oscillator
- AVIR 29.52
- TTEC 47.76
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About TTEC TTEC Holdings Inc.
TTEC Holdings Inc provides customer engagement management tools and services. The company operates through four operating segments that are organized into two groups, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and most of the sales are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.